Major Histocompatibility Complex Class II DR Beta 3 (MHCDRb3)

[Edit]

HLA-DRB3; HLA-DR3B; HLADRb3; HLA class II histocompatibility antigen, DR beta 3 chain; MHC class II antigen DRB3

Major Histocompatibility Complex Class II DR Beta 3 (MHCDRb3)
Class II major histocompatibility complex molecules present antigens to CD4 -positive cells. Human class II MHC molecules are of 3 major isotypes, HLA-DR, HLA-DP, and HLA-DQ , each of which consists of an alpha and a beta chain. Both the alpha and beta chains of HLA-DP and HLA-DQ are polymorphic, whereas HLA-DR alpha is invariant and HLA-DR beta is polymorphic. Thus, differences in the HLA-DR beta chain account for different peptide-binding motifs of HLA-DR molecules. The most highly expressed HLA-DR beta chain is encoded by the extremely polymorphic HLA-DRB1 gene. Most of the alternate beta chain genes linked to HLA-DRB1 are pseudogenes, but HLA-DRB3, HLA-DRB4, and HLA-DRB5 encode functional proteins. HLA-DRB3 is also known as HLA-DR52 and has 3 major alleles: DRB3*0101 (DR52a), DRB3*0202 (DR52b), and DRB3*0301 (DR52c) .

Organism species: Homo sapiens (Human)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant Major Histocompatibility Complex Class II DR Beta 3 (MHCDRb3) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to Major Histocompatibility Complex Class II DR Beta 3 (MHCDRb3) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Major Histocompatibility Complex Class II DR Beta 3 (MHCDRb3) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Major Histocompatibility Complex Class II DR Beta 3 (MHCDRb3) CLIA Kit Customized Service Offer
n/a ELISA Kit for Major Histocompatibility Complex Class II DR Beta 3 (MHCDRb3) ELISA Kit Customized Service Offer
  1. "Complete sequence of an HLA-DR beta chain deduced from a cDNA clone and identification of multiple non-allelic DR beta chain genes."EMBO J. 2:389-394(1983) [PubMed] [Europe PMC] [Abstract]
  2. "Polymorphism of human Ia antigens: gene conversion between two DR beta loci results in a new HLA-D/DR specificity."Nature 322:67-70(1986) [PubMed] [Europe PMC] [Abstract]
  3. "Description of two new HLA-DRB alleles (DRB1*0310 and DRB3*01012) found in a Spanish infant."Tissue Antigens 49:658-661(1997) [PubMed] [Europe PMC] [Abstract]
  4. "DRB3 alleles with variations in the annealing sites of commonly used amplification primers."Tissue Antigens 55:558-563(2000) [PubMed] [Europe PMC] [Abstract]
  5. "DNA sequences coding for the DR beta-chain locus of the human lymphocyte antigen complex and polypeptides, diagnostic typing processes and products related thereto."Patent number EP0103960, 28-MAR-1984
  6. "The DNA sequence and analysis of human chromosome 6." Nature 425:805-811(2003) [PubMed] [Europe PMC] [Abstract]
  7. "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
  8. "Molecular analysis of the genes for human class II antigens of the major histocompatibility complex."Hum. Immunol. 8:113-121(1983) [PubMed] [Europe PMC] [Abstract]
  9. "Allelic variation in the DR subregion of the human major histocompatibility complex."Proc. Natl. Acad. Sci. U.S.A. 84:6234-6238(1987) [PubMed] [Europe PMC] [Abstract]
  10. "Identification by sequencing based typing and complete coding region analysis of three new HLA class II alleles: DRB3*0210, DRB3*0211 and DQB1*0310."Tissue Antigens 56:380-384(2000) [PubMed] [Europe PMC] [Abstract]
  11. "Sequencing of two new HLA class II alleles: DRB3*0218 and DQB1*030202."Tissue Antigens 63:614-616(2004) [PubMed] [Europe PMC] [Abstract]
  12. "Identification of a new DRB3*02 allelic variant (DRB3*0209) by high-resolution sequence-based typing."Tissue Antigens 56:90-94(2000) [PubMed] [Europe PMC] [Abstract]
  13. "Description of fourteen new DRB alleles found in a stem cell donor registry."Tissue Antigens 59:63-65(2002) [PubMed] [Europe PMC] [Abstract]
  14. "Three new DRB alleles routinely identified by sequence-based typing: DRB1*010103, DRB1*0326 and DRB3*0219."Tissue Antigens 64:621-623(2004) [PubMed] [Europe PMC] [Abstract]
  15. "Characterisation of two novel HLA alleles, HLA-Cw*0429 and HLA-DRB3*0223."Tissue Antigens 72:498-499(2008) [PubMed] [Europe PMC] [Abstract]
  16. "Description of three novel HLA-DRB3 alleles: DRB3*010105, DRB3*0112 and DRB3*0113."Tissue Antigens 73:83-84(2009) [PubMed] [Europe PMC] [Abstract]
  17. "Diversity associated with the second expressed HLA-DRB locus in the human population."Immunogenetics 46:104-110(1997) [PubMed] [Europe PMC] [Abstract]
  18. "Identification of new DRB1*01 (DRB1*01022), DRB1*14 (DRB1*1428) and DRB3* (DRB3*0206) alleles."Tissue Antigens 50:89-93(1997) [PubMed] [Europe PMC] [Abstract]
  19. "A novel DRB3 allele (DRB3*0208), a new allelic variant of DRB1*1502 (DRB1*15023) and two new DQB1 (DQB1*03012 and DQB1*0614) alleles."Tissue Antigens 52:294-299(1998) [PubMed] [Europe PMC] [Abstract]
  20. "Identification of three new DRB3* (DRB3*0106, DRB3*0107 and DRB3*02022) alleles."Tissue Antigens 57:390-393(2001) [PubMed] [Europe PMC] [Abstract]
  21. "Identification of three novel alleles: DRB3*0110, DRB1*1140, and DRB1*140102."Tissue Antigens 63:496-500(2004) [PubMed] [Europe PMC] [Abstract]
  22. "New HLA class II alleles in the Indonesian population."Tissue Antigens 54:521-523(1999) [PubMed] [Europe PMC] [Abstract]
  23. "Identification and nucleotide sequence of two novel DRB3 alleles, DRB3*0102 and DRB3*010133."Tissue Antigens 49:665-667(1997) [PubMed] [Europe PMC] [Abstract]
  24. "Identification of a new DRB3*02 allele (DRB3*0207) by sequence-based typing."Tissue Antigens 50:552-554(1997) [PubMed] [Europe PMC] [Abstract]
  25. "HLA-DR beta-chain polymorphism. Second domain polymorphism reflects evolutionary relatedness of alleles and may explain public serologic epitopes."J. Immunol. 143:329-333(1989) [PubMed] [Europe PMC] [Abstract]
  26. "Naturally processed peptides spanning the HPA-1a polymorphism are efficiently generated and displayed from platelet glycoprotein by HLA-DRB3*0101-positive antigen-presenting cells."Blood 114:1954-1957(2009) [PubMed] [Europe PMC] [Abstract]
  27. "Invariant chain structure and MHC class II function."Cell 84:505-507(1996) [PubMed] [Europe PMC] [Abstract]
  28. "Presentation of antigens by MHC class II molecules: getting the most out of them."Mol. Immunol. 38:329-346(2001) [PubMed] [Europe PMC] [Abstract]
  29. "Autophagy in MHC class II presentation: sampling from within."Immunity 26:1-3(2007) [PubMed] [Europe PMC] [Abstract]
  30. "MHC class II molecules on the move for successful antigen presentation."EMBO J. 27:1-5(2008) [PubMed] [Europe PMC] [Abstract]
  31. "MHC class II stabilization at the surface of human dendritic cells is the result of maturation-dependent MARCH I down-regulation."Proc. Natl. Acad. Sci. U.S.A. 105:3491-3496(2008) [PubMed] [Europe PMC] [Abstract]
  32. "MHC class II transport at a glance."J. Cell Sci. 122:1-4(2009) [PubMed] [Europe PMC] [Abstract]
  33. "CD74 in antigen presentation, inflammation, and cancers of the gastrointestinal tract."World J. Gastroenterol. 15:2855-2861(2009) [PubMed] [Europe PMC] [Abstract]
  34. "Crystallographic structure of the human leukocyte antigen DRA, DRB3*0101: models of a directional alloimmune response and autoimmunity."J. Mol. Biol. 371:435-446(2007) [PubMed] [Europe PMC] [Abstract]
  35. "The structure of HLA-DR52c: comparison to other HLA-DRB3 alleles."Proc. Natl. Acad. Sci. U.S.A. 105:11893-11897(2008) [PubMed] [Europe PMC] [Abstract]